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Pulmonary tuberculosis, caused by Mycobacterium tuberculosis (M.tb) represents a
leading global health concern, with 8.7 million newly emerging cases, and 1.4 million
reported deaths annually. Despite an estimated one third of the world’s population
being infected, relatively few infected individuals ever develop active clinical disease.
The ability of the host to remain latently infected while preventing disease is thought
to be due to the generation of a robust type 1 immune response in the lung, capable
of controlling, but not clearing, M.tb. A key feature of the type 1 immune response to
M.tb is the formation of immune cellular aggregates termed granuloma. The granuloma
structure has long been considered a hallmark of host’s protective response toward
M.tb. Historically, a correlative relationship between granuloma formation/maintenance
and bacterial control has been seen in models where disrupted granuloma formation
or structure was found to be fatal. Despite this established relationship much about
the granuloma’s role in M.tb immunity remains unknown. Recent publications suggest
that the granuloma actually aids the persistence of M.tb and that the development
of a necrotic granuloma is essential to person-to-person transmission. Our group and
others have recently demonstrated that enclosed within the granuloma is a population of
immunologically altered antigen-presenting cells and T lymphocyte populations. Of note,
the ability of these populations to produce type 1 cytokines such as interferon-gamma,
and bactericidal products including nitric oxide, are signiﬁcantly reduced, while remaining
competent to produce high levels immunosuppressive interleukin-10. These observations
indicate that although the chronic granuloma represents a highly unique environment, it is
more similar to that of a tumor than an active site of bacterial control. In this review we will
explorewhat is known about this unique environment and its contribution to the persistence
of M.tb.
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INTRODUCTION
Pulmonary tuberculosis (TB) caused by infection with Mycobac-
terium tuberculosis (M.tb) is the leading cause of death due to a
bacterial pathogen and is responsible for 1.4 million deaths annu-
ally, latently infecting one third of the world’s population (WHO,
2012). Despite the magnitude of individuals infected, the rate
of mortality is relatively low with approximately 90% infected
individuals controlling, but not clearing, M.tb (WHO, 2012).
The ability of the host to “control” M.tb infection encompasses
a number of immunological processes designed to restrain bacte-
rial dissemination and persistence, and reduce person-to-person
transmission. The classical hallmark of anti-TB host defense is
the formation of type 1 immune granuloma in the lung. Histor-
ically, the granuloma has been perceived as essential to anti-TB
host defense as the host is incapable of sterile clearance and thus
is forced to segregate the infected cells as a means to preserve
itself. However, experimentally little is known of the role of the
granuloma in bacterial control.
THE HISTORICAL VIEW OF MYCOBACTERIAL GRANULOMA
First described in 1679, pathologists discovered unique structures
in the lungs of TB patients (de le Boe, 1679; reviewed in Ramakr-
ishnan, 2012). These structures were then termed tubercles and
represent what we now know as granulomas. Commonly, it was
observed that persons who had died of TB had a large number of
these distinct pathological lesions, and the presence of tubercles
became an associated hallmark of activeTBdisease. It was not until
1884 that tubercles were also characterized in individuals who had
died from diseases other than TB. Upon post-mortem examina-
tion, a number of these individuals had lung lesions (granulomas)
containing live TBbacilli, giving the ﬁrst indication that TB latency
may relate to the formation of granuloma (Dejerine, 1884). How-
ever, upon further microbiological examination, it was revealed
that live bacilli persisted not only within the granuloma itself,
but also in the surrounding lung tissue, albeit to a lesser degree
(Wang, 1916; Opie and Aronson, 1927; Robertson, 1933; Feldman
and Baggenstoss, 1938, 1939). It was around this time that the
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protective view of the granuloma began to gain public acceptance
and it was proposed that the recruitment of activated lymphocytes
and the formation of a lymphocytic cuff served towall-off infected
macrophages as a means of limiting dissemination. However, the
role of granuloma in TB has remained enigmatic largely because
of the unavailability of reliable animal models and appropriate
techniques to observe the dynamic process of granuloma evolu-
tion. Although different experimental models (mice, guinea pig,
rabbit, cattle, and macaque) have been developed, only cattle and
macaquemonkeys form the type of granuloma that closely resem-
bles those seen in humans (Capuano et al., 2003; Flynn et al., 2003;
Tsai et al., 2006; Hunter et al., 2007; Via et al., 2008). Despite being
extensively used as a model of TB, the murine granuloma lacks
many of the unique characteristic features of the human granu-
loma including centralized necrosis, giantmultinuclear cells, and a
deﬁned“lymphocytic cuff” (Rhoades et al., 1997). Contrasting the
classical notion of its protective role, a number of recent studies
have demonstrated unaltered bacterial control even in the absence
of granuloma formation, strongly arguing against the granuloma
being essential to bacterial restriction (Johnson et al., 1998; Scott
and Flynn, 2002; Pearl et al., 2004). Moreover, it is now known
that the Mycobacterium can signiﬁcantly alter the immune envi-
ronment of the granuloma asmeans to facilitate its persistence (Ly
et al., 2007; Scott-Browne et al., 2007; Marino et al., 2010; Castano
et al., 2011; O’leary et al., 2011). Regardless, the common percep-
tion remains that the granuloma serves to limit bacterial growth
and prevent dissemination by segregating infected cells, and the
role of the granuloma inM.tb infection remains an issue of contin-
ued debate. In this review we will challenge the traditional view of
the function of granuloma, exploring what is known about its pro-
gression and maturation, and how this unique environment may
in fact contribute to the persistence and transmission of M.tb.
FORMATION OF THE TYPE 1 IMMUNE GRANULOMA DURING
M.tb INFECTION
The formation of granuloma is a dynamic process that begins
shortly after infection and continuously evolves over time. Tem-
porally, the granuloma can be divided into three distinct phases:
(1) the “innate granuloma,” a loose aggregate composed primar-
ily of recruited macrophages and neutrophils; (2) the “immune
granuloma” formed following the emergence of antigen-speciﬁc
T cells; and (3) the “chronic granuloma,” resulting from distinct
morphological changes in granuloma structure (Figure 1).
FORMATION OF THE “INNATE GRANULOMA”
Shortly after aerosol exposure, M.tb infects the resident alveo-
lar macrophage (AM) initiating the early inﬂammatory response.
While amplifying the host immune response, the recruitment of
innate immune cells inadvertently provides a large number of new
targets for M.tb to infect and is thought to contribute to the early
dissemination of M.tb (Doenhoff, 1997; Davis and Ramakrish-
nan, 2009). Augmenting this problem, the infected AM is unable
to kill internalized mycobacteria due to impaired phagolysosome
fusion, a process essential to the destruction of the phagocytosed
bacteria (Welin et al., 2011). The efﬁciency by which a Mycobac-
terium species arrests phagolysosome fusion is directly attributable
to its relative virulence, with highly virulent strains such as M.tb
almost completely inhibiting fusion (Ferrer et al., 2010). Incapable
of killing internalized M.tb, infected macrophages secrete an array
of pro-inﬂammatory and chemoattractant cytokines including
tumor necrosis factor (TNF), interleukin (IL)-6, and IL-8 which
facilitate the recruitment of newmacrophages and granulocytes to
the site of infection and lead to the formation of the“innate granu-
loma” (Birkness et al., 2007). This initial recruitment is essential to
establishing the macrophage-dominated center of the “immune”
granuloma.
CONTRIBUTION OF M.tb TO THE FORMATION OF THE “INNATE
GRANULOMA”
Historically the formation of granuloma has been considered to
be a host-mediated event. Using an M. marinum model, real-time
microscopic visualization has challenged this notion, revealing
that virulent Mycobacterium drives the nascent formation of the
early granuloma. A number of elegant studies conducted by
Ramakrishnan’s group have demonstrated the unique interplay
between the Mycobacterium and the host immune system in the
early stage of granuloma formation. To this end, the early release of
6 kDa early secretory antigenic target (ESAT-6) byM.marinum led
to the activation of the epithelium, which facilitated the recruit-
ment of macrophages to the site of infection through inducing the
production of matrix metalloproteinase-9 (MMP-9) (Davis and
Ramakrishnan, 2009; Volkman et al., 2010). In murine models,
M.tbwas also found to driveMMP-9 expression. Thus either broad
MMP inhibition orMMP-9-speciﬁc depletion delayed granuloma
formation, resulting in impaired macrophage recruitment to the
site of infection and reduced granuloma size (Taylor et al., 2006).
These ﬁndings indicate thatM.tbmay actually promote granuloma
formation and utilizes the structure for its own beneﬁt. Further-
more, it was demonstrated that virulent mycobacteria can utilize
the innate granuloma as means of recruiting target cells allowing
for the early dissemination of mycobacteria throughout the host
(Davis and Ramakrishnan, 2009). This view is supported further
by the observation that the early granuloma is not a static environ-
ment and there is a signiﬁcant movement of antigen-presenting
cell (APC) populations into and out of the early granuloma (Chiu
et al., 2004; Egen et al., 2008, 2011; Schreiber et al., 2011).
FORMATION OF THE “IMMUNE GRANULOMA”
Following innate activation, dendritic cells are recruited to the
lung and transport mycobacteria or mycobacterial antigens to
the mediastinal lymph node (MLN). Within the MLN antigen-
loaded APCs activate antigen-speciﬁc T cells. Due to the nature
of M.tb infection, the majority of bacilli and antigen reside within
an endosome, and are most efﬁciently loaded onto major histo-
compatibility complex (MHC) class II (Mogues et al., 2001; Anis
et al., 2008; Yahagi et al., 2010). The loading of MHC class II facil-
itates the priming of Th1 interferon-gamma (IFN-γ)-secreting T
cells, which rapidly home to the lung. While the dominant subset
of T cells are CD4+, cross-presentation also allows for the strong
induction of CD8+ T cells, collectively generating a type 1 polar-
ized adaptive immune response (Winau et al., 2006). Although
outside the scope of this review, it should be noted that there is a
substantial lag period between M.tb infection and the initiation of
antigen-speciﬁc T cell responses (reviewed in Shaler et al., 2012).
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FIGURE 1 | Evolution ofTB granuloma formation. Following infection sentinel macrophages cells facilitate M.tb uptake and the recruitment of other innate
and adaptive immune cells.
The continuous production of chemokines by infected lung
APCs efﬁciently recruits newly primed T cells into the lung. Once
in the lung, recruited T cells surround and wall-off infected
macrophages, activate them for enhanced bactericidal function,
and physically limit their mobility to restrain bacterial dissemina-
tion. Indeed, the arrival of effector T cells and the establishment
of the classical “immune granuloma” is associated with a plateau
in bacterial growth (Mogues et al., 2001). While the prevailing
immune response generated following M.tb infection is highly
similar between the mouse and man, the structural formation of
the “immune granuloma” differs signiﬁcantly. In mice, many of
the hallmark features of the human granuloma are missing, and
thus the knowledge from murine granuloma research should be
interpreted with caution. Despite these limitations, animal mod-
els have provided signiﬁcant insight, and have been invaluable in
delineating the stages of granuloma formation.
THE CONTROVERSIAL REQUIREMENT OF THE “IMMUNE GRANULOMA”
IN LIMITING BACTERIAL DISSEMINATION
In spite of the traditional protective view of granuloma, it has
recently been revealed that the immune environment within gran-
uloma is more conducive to M.tb persistence than its elimination.
Despite the fact that animal models do not accurately replicate
human granuloma structures, several murine studies have pro-
vided invaluable insight into the role of granuloma in preventing
M.tb dissemination control. Early studies demonstrating the role
of critical cytokines such as TNF and IFN-γ perpetuated the
notion that the granuloma was essential for bacterial segrega-
tion and limiting bacterial growth in the lung as the absence of
either cytokine led to ill-formedgranulomaand increasedbacterial
infection (Flynn et al., 1998; Kaneko et al., 1999; Algood et al.,
2005; Beham et al., 2011; Gallegos et al., 2011). Moreover, any
loss of CD4+ T cell functionality results in a loss of the gran-
uloma structure and extensive bacterial dissemination is seen in
both man and mouse. While essential to the control of M.tb, the
role of the CD4+ T cell in the granuloma’s structure is somewhat
species-dependent. Speciﬁcally, in humans, T cells surround and
wall-off infected macrophages, and do not inﬁltrate the granu-
loma, but rather form a deﬁned lymphocytic cuff. Conversely,
murine CD4+ T cells associate directly with infected cells inﬁltrat-
ing throughout the granuloma forming lymphocytic aggregates or
pseudo-granulomas (Mogues et al., 2001; Tsai et al., 2006; Hunter
et al., 2007; Via et al., 2008; Gallegos et al., 2011; Geldmacher et al.,
2012). Nevertheless, while the loss of CD4 T cell-mediated immu-
nity is detrimental to the host it is impossible to separate the
relative contribution of the two processes to the impaired bacterial
control: loss of Th1-mediated immunity and loss of granuloma
structure, these studies suggest a critical role for the granuloma in
preventing bacterial dissemination (Saunders et al., 2002; Segovia-
Juarez et al., 2004). The essential role of CD4 T cells to the control
of mycobacterial growth has largely been attributed to their potent
IFN-γ production and subsequent macrophage activation. While
macrophage activation is essential to the control of M.tb in mouse
and man, the role of nitric oxide has been an issue of some
debate. Historically, studies have shown that human macrophages
do not produce nitric oxide to the same degree in vitro as those
isolated from mice (Aston et al., 1998). Recently, however, sev-
eral groups have demonstrated that human macrophages from
TB infected patients, as well as human macrophage cells lines are
capable of inducing iNOS and producing nitric oxide in response
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to M.tb antigen (Rich et al., 1997; Jagannath et al., 1998; Dlu-
govitzky et al., 2000). Indeed, it appears that while the timing
of nitric oxide and its role in TB control may differ somewhat
between mouse and man, nitric oxide remains important in both
species.
Recent studies suggest that the granuloma may be dispensable
for preventing bacterial dissemination andmay actually contribute
toM.tb persistence. Moreover, in the absence of intracellular adhe-
sion molecule-1 (ICAM-1), there is also a failure of granuloma
formation, and despite this defect, mice are protected for the ﬁrst
90 days post-infection, with no increase in bacterial growth com-
pared to wildtype mice within this time frame (Johnson et al.,
1998). Similarly, zebraﬁsh models have shown that in the absence
of early granuloma formation, there is no defect in the ability of
the host to limit bacterial replication and dissemination, and that
the granuloma may actually facilitate early dissemination (Volk-
man et al., 2004, 2010). Furthermore, in the absence of IL-27 in
mice, there is a substantial defect in the ability of the host to
form granuloma in response to M.tb infection, and yet infected
mice exhibit markedly enhanced bacterial control when compared
to their wildtype counterparts (Pearl et al., 2004). Indeed, recent
studies indicate that granuloma does not always function to limit
bacterial dissemination. For example, C-C chemokine receptor
type 2 (CCR2) deﬁcient mice form exaggerated granuloma struc-
tures when infected with M.tb and paradoxically have a decreased
capacity to control bacterial growth (Scott and Flynn, 2002).
While it remains debatable whether the granuloma is required
for bacterial control, growing evidence supports the notion that
the fate of M.tb within the granuloma is situation-dependent. For
example, the initial inoculum size may inﬂuence the number of
macrophages and granulocytes that are recruited to the site of
infection. If a large number of cells are initially recruited, spa-
tially it becomes difﬁcult for effector T cells to interact with the
infected cells residing at the core of the granuloma limiting their
ability to activate these centralizedmacrophages to kill internalized
M.tb (Segovia-Juarez et al., 2004). In comparison, a small initial
inoculum size infects a small number of cells at the core of granu-
loma, which may increase the likelihood of interaction of infected
cells with effector T cells (Segovia-Juarez et al., 2004). Based on
this notion, it is tempting to speculate that a stronger initial innate
immune responsemay perpetuate the infection and limit the host’s
ability to eliminate M.tb. Therefore, a small-size granuloma may
favor host defense whereas a relatively large-size counterpart may
favor the persistence of mycobacterial bacilli, regardless of the
magnitude of T cells generated. The current limitation to diag-
nostic imaging makes studying the evolution of the granuloma
in latently infected humans difﬁcult and as a consequence, little is
known about how its structure changes over the course of infection
in otherwise healthy individuals.
THE “IMMUNE GRANULOMA”: A NICHE FOR BACTERIAL PERSISTENCE
Regardless of whether the granuloma functions to limit bacte-
rial dissemination, much evidence suggests that M.tb is especially
adept at altering the immune response within the granuloma,
creating a uniquely suppressed environment largely through the
induction of IL-10 (de Waal Malefyt et al., 1993; Chiu et al., 2007,
2008; Higgins et al., 2009; Marino et al., 2010; Redford et al., 2010;
O’leary et al., 2011; Shaler et al., 2011). Functionally, the infected
macrophages within the granuloma are altered, showing a reduced
capacity to produce bactericidal products such as nitric oxide,
while showing enhanced IL-10 production (deWaal Malefyt et al.,
1993; Chiu et al., 2007, 2008; Higgins et al., 2009; Marino et al.,
2010; Redford et al., 2010; O’leary et al., 2011; Shaler et al., 2011).
Interestingly, while the macrophage populations of the granu-
loma have reduced bactericidal function, they continue to produce
large amounts of chemokines facilitating the continuous recruit-
ment APC populations into the granuloma (Schreiber et al., 2010;
Shaler et al., 2011). Recent studies utilizing intravital microscopy
have revealed signiﬁcant movement of inﬂammatory APCs both
into and out of the granuloma (Schreiber et al., 2011). It is this
movement of infected APCs that has been speculated to facili-
tate the early dissemination of M.tb. Likewise, human granuloma
contains a high frequency of foxp3+ T regulatory cells (Rahman,
2009). In addition, murine studies have conﬁrmed that T cells
residing within the granuloma display a highly altered, and func-
tionally suppressed phenotype. Despite the central role of IL-10
in suppressing T cell and macrophage activation within the gran-
uloma, IL-10 neutralization or infection of IL-10 knockout (KO)
mice results in only marginally reduced bacterial loads (de Waal
Malefyt et al., 1993; Jacobs et al., 2002; Chiu et al., 2007; Higgins
et al., 2009). Given M.tb’s long evolution with humans, it is not
surprising that M.tb targets multiple pathways to interrupt the
host immune response. Moreover, while conventionally immune
suppression would appear to beneﬁt only the pathogen, the induc-
tion of IL-10 may actually be a host-mediated event required to
limit unwanted immunopathology.
THE “CHRONIC GRANULOMA”: A DYNAMIC INTERPLAY BETWEEN
PERSISTING M.tb AND THE HOST IMMUNE RESPONSE
Following the establishment of the“immune granuloma,” a period
of immune quiescence is established. It is during this stage that
chronic immune activation leads to signiﬁcant alterations in the
morphology and functionality of the granuloma, many of which
are not typically seen in mice. Post-mortem studies of latently
infected humans and non-human primates have revealed that the
evolution of the granuloma structure is highly divergent, not only
between individuals, but even within a single individual (Capuano
et al., 2003; Flynn et al., 2003; Barry et al., 2009). Typically, within
an infected individual, a spectrum of granuloma structures are
seen. For instance, both the fully calciﬁed lesions containing no
bacilli and the ﬁbrotically encapsulated necrotic granulomas con-
taining large numbers of live bacteria can be seen in the lung of the
same individual, indicating that the evolution of the granuloma is
a highly dynamic process (Capuano et al., 2003; Flynn et al., 2003;
Barry et al., 2009).
While the granuloma has long been believed to be a protective
host’s response, it is now acknowledged to result from a dynamic
and continuous interplay between the host’s immune response and
persistingM.tb. The continuous“battle”between chronic immune
activation and bacterial persistence causes infected macrophages
to adopt an irregular epithelial-like or “epithelioid” appearance,
and to fuse together forming multinucleated giant cells in the core
of granuloma (Hunter et al., 2007; Hunter, 2011). Indeed, the vir-
ulent Mycobacterium has been shown to induce macrophage cell
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death frequently throughout the course of infection, which sev-
eral studies have shown to be a potential mechanism of gaining
access to new host macrophages (Davis and Ramakrishnan, 2009).
Newly recruitedmacrophages quickly phagocytose the deadbodies
and become saturated with mycobacteria and lipids (Peyron et al.,
2008). These lipid-rich macrophages that accumulate within the
granuloma are known as foamy macrophages due to their distinct
appearance, and are now recognized as a major contributing fac-
tor in the persistence of M.tb (Peyron et al., 2008). Recent studies
have shown that foamy macrophages isolated from humans have
lost key functions including their ability to phagocytose and to
produce essential bactericidal agents such as nitric oxide (Peyron
et al., 2008). Moreover, the polarization of macrophage popula-
tions within the granuloma are thought to shift from being a
classically activated (M1) population toward that of an alterna-
tively activated (M2), with reduced bactericidal capacity (Redente
et al., 2010). Thus, such foamy macrophages have been proposed
to function as the reservoirs of M.tb whereby the bacterium is able
to successfullymanipulate the infectedmacrophage into not only a
safe haven but also a source of nutrients required for the synthesis
of its cell wall and replication.An infected host typically houses a
highly heterogeneous mixture of granuloma types ranging from
large necrotic granulomas containing large amounts of bacilli, to
completely calciﬁed structures devoid of any detectible bacteria
(Turner et al., 2003; Hunter et al., 2007; Hunter, 2011). In the later
stages of granuloma evolution, ﬁbrotic encapsulation can be seen
in cases of both active and latent infection. Currently, it is unclear
whether encapsulation functions to prevent bacterial escape, or to
limit immune inﬁltration into the granuloma. Although complete
mycobacterial clearance is rarely seen, latently infected humans
display the evidence of healed granulomas, marked by central cal-
ciﬁcation in conjunction with ﬁbrotic encapsulation containing
no detectible bacilli (Opie, 1917). Despite the observed absence of
bacteria within highly calciﬁed granulomas, it is currently unclear
whether this represents immune-mediated clearance, or simply a
structural artifact left behind following M.tb escape.
Mycobacterium tuberculosis FACILITATES PERSON-TO-PERSON
TRANSMISSION THROUGH ALTERATIONS TO THE GRANULOMA
Despite the attempts of the host to contain M.tb within the gran-
uloma, as the infection progresses, the majority of individuals will
develop granulomaswith a necrotic focus formed due to the caesa-
tion of the macrophage infused center (Kim et al., 2010; Figure 2).
This eventual necrosis of the granuloma is now accepted as a
necessary event in facilitating the transmission of M.tb by dis-
rupting the lung structure and allowing M.tb to gain access to the
major airways. It should be noted that, in addition to person-to-
person transmission, the active granuloma leaking bacteria into
the airways may also allow for intrapulmonary dissemination
(Cardona, 2009, 2010; Cardona and Ivanyi, 2011). It is there-
fore likely that the heterogeneity in granuloma structure seen in
different lung regions of the same host represents different evo-
lutionary timelines. Although much remains to be understood,
it is clear that the evolution of granuloma is the result of the
dynamic interplay between persisting mycobacteria and the host
immune response, continuously evolving throughout the course
of M.tb infection. Interestingly, M.tb may actually utilize the host
FIGURE 2 |The failure of theTB granuloma.The characteristic changes
associated with the disintegration of theTB granuloma required for
dissemination.
immune response to facilitate the structural changes required to
facilitate person-to-person transmission. In line with this, while
essential to preventing bacterial dissemination, paradoxically IFN-
γ-producing Th1 cellsmay also play an integrate role in facilitating
bacterial transmission (Ehlers et al., 2001). The ability of M.tb
to manipulate the host immune response as means to facilitate
central granuloma necrosis and facilitate its transmission while
deterring immune-mediated bacterial clearance is a remarkable
but poorly understood feature of M.tb. It is important to note
that the processes of bacterial dissemination within a host, and
transmission between hosts may be independently regulated. For
instance, clinically it has been observed that despite exaggerated
bacterial burdens and extensive dissemination, HIV-AIDS indi-
viduals co-infected with M.tb transmit M.tb person-to-person
far less efﬁciently (Doenhoff, 1997; Ledru et al., 1999; Corbett
et al., 2003; Glynn et al., 2008). The inability of the HIV-infected
host to spread M.tb has been attributed to a failure of M.tb to
drive central granuloma necrosis and cavitation, and the trans-
port of bacilli to the airway. These observations argue that M.tb
utilizes the necrotic granuloma as a portal for person-to-person
transmission.
While it is well-known that changes to the granuloma structure
are required for bacterial transmission, it is currently unknown
whether the host or bacteria are responsible for these changes.
Recently, studies have examined the granuloma at early and
chronic stages of disease revealing a dramatic shift in the genes
expressed by both M.tb and the host immune response. Notably,
within the granuloma, the host immune response shifts from pre-
dominately pro-inﬂammatory during the early phases of infection,
to immunosuppressive during the chronic stages (Karakousis et al.,
2004; Ly et al., 2007; Mehra et al., 2010). Coincidentally, M.tb
expresses a deﬁned set of genes that function to facilitate immune
www.frontiersin.org February 2013 | Volume 4 | Article 30 | 5
“ﬁmmu-04-00030” — 2013/2/12 — 15:23 — page 6 — #6
Shaler et al. Granuloma andTB persistance
activation, while simultaneously expressing enzymes to combat
immune-mediated clearance (Rohde et al., 2012). This is later fol-
lowed by a shift in gene expression thought to facilitate immune
senescence within the granuloma, allowing for M.tb’s persistence
(Rohde et al., 2012). While traditionally M.tb is thought to lie
dominant, it has recently been demonstrated that throughout the
course infection M.tb will periodically “awaken,” up-regulating a
number genes and sample the immune environment (Karakousis
et al., 2004). This sampling allows M.tb to identify the optimal
conditions for facilitating person-to-person transmission. More-
over, during the caseous stage of granuloma formation there
is a further shift in the genes expressed by M.tb with a signif-
icant up-regulation of genes associated with lipid metabolism
(Kim et al., 2010). Notably, most mycobacterial species are rich in
immunomodulatory lipids, which play a central role in immune
evasion. Intriguingly, the distribution and release of certain lipids
by M.tb varies signiﬁcantly over the course of infection, provid-
ing a means by which M.tb directs the host immune response.
To this end, M.tb can release toxic lipids and generate targeted
tissue damage. The generation of central necrosis is essential to
facilitating cavitation andpromotingM.tb transmission. Trehalose
6,6′-dimycolate (cord factor) has potent cytotoxic effects and has
been implicated in the generation of central necrosis of the gran-
uloma and the transmission of M.tb (Hunter et al., 2006; Kim
et al., 2010). Recently, it has been shown that neutrophils and
AMs recognize mycobacterial cord factor through their surface c-
type lectin receptor, mincle (Behler et al., 2012; Lee et al., 2012).
The engagement of mincle leads to a pro-inﬂammatory cytokine
pathway that aids in the early cellular recruitment and control of
mycobacteria (Behler et al., 2012; Lee et al., 2012). Interestingly,
however, the proportion of cord factor varies greatly throughout
the course of infection with its synthesis heavily up-regulated
by M.tb during the development of central necrosis and cavita-
tion (Hunter et al., 2006; Kim et al., 2010). Indeed, studies have
linked the amount of cord factor released by M.tb to the extent
of necrosis and cavity formation (Hunter et al., 2006; Kim et al.,
2010). Moreover, previous studies have documented mincle as a
key receptor in the detection of necrosis and the development of
an inﬂammatory response upon tissue damage (Yamasaki et al.,
2008). Given that cord factor is known for its cytotoxic effects,
one may speculated that engaging mincle may be central to the
development of a pro-inﬂammatory response capable of aiding
the formation of cavitation within the granuloma. Utilizing the
host immune machinery M.tb facilitates the necessary structural
changes to ensure its own transmission, which occurs at a time
when the immune system is most vulnerable.
CONCLUDING REMARKS
While the true nature of the granuloma still remains to be deﬁned,
it is now clearly evident that the granuloma is not just a host-
mediated entity of segregation and rather, it is a dynamicbattleﬁeld
bearing the scars left both by the pathogen and the host immune
response. While it may have been originally destined to restrain
bacterial dissemination, M.tb efﬁciently hijacks the granuloma to
provoke the generation of an immunologically sheltered niche to
reside within and persist until the situation is favorable to bacterial
transmission.
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